Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
about
LATERAL FLOW ASSAY FOR CRYPTOCOCCAL ANTIGEN: AN IMPORTANT ADVANCE TO IMPROVE THE CONTINUUM OF HIV CARE AND REDUCE CRYPTOCOCCAL MENINGITIS-RELATED MORTALITYExtensive Central Nervous System Cryptococcal Disease Presenting as Immune Reconstitution Syndrome in a Patient with Advanced HIV: Report of a Case and Review of Management Dilemmas and StrategiesIntegrated therapy for HIV and cryptococcosisHIV-Associated Cryptococcal Meningitis: Bridging the Gap Between Developed and Resource-Limited SettingsA novel experimental model of Cryptococcus neoformans-related immune reconstitution inflammatory syndrome (IRIS) provides insights into pathogenesis.Unmasking cryptococcal meningitis immune reconstitution inflammatory syndrome in pregnancy induced by HIV antiretroviral therapy with postpartum paradoxical exacerbation.Prevalence of cryptococcal infection among advanced HIV patients in Argentina using lateral flow immunoassay.Very low levels of 25-hydroxyvitamin D are not associated with immunologic changes or clinical outcome in South African patients with HIV-associated cryptococcal meningitis.Clinical and immunologic predictors of death after an acute opportunistic infection: results from ACTG A5164.Rapid diagnosis of cryptococcal meningitis by use of lateral flow assay on cerebrospinal fluid samples: influence of the high-dose "hook" effect.Massive cerebral edema resulting in brain death as a complication of Cryptococcus neoformans meningitis.Detection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal MeningitisCytokine profiles at admission can be related to outcome in AIDS patients with cryptococcal meningitisCerebrospinal fluid cytokine profiles predict risk of early mortality and immune reconstitution inflammatory syndrome in HIV-associated cryptococcal meningitisCryptococcosis diagnosis and treatment: What do we know nowRapid microscopy and use of vital dyes: potential to determine viability of Cryptococcus neoformans in the clinical laboratory.The effect of therapeutic lumbar punctures on acute mortality from cryptococcal meningitis.Paradoxical Immune Responses in Non-HIV Cryptococcal MeningitisTreatment principles for Candida and Cryptococcus.Genotypic Diversity Is Associated with Clinical Outcome and Phenotype in Cryptococcal Meningitis across Southern AfricaAnalysis of cerebrospinal fluid protein concentrations of patients with cryptococcal meningitis treated with antifungal agents.AMBITION-cm: intermittent high dose AmBisome on a high dose fluconazole backbone for cryptococcal meningitis induction therapy in sub-Saharan Africa: study protocol for a randomized controlled trial.Cryptococcal Antigenemia in Immunocompromised Human Immunodeficiency Virus Patients in Rural Tanzania: A Preventable Cause of Early Mortality.Early ART After Cryptococcal Meningitis Is Associated With Cerebrospinal Fluid Pleocytosis and Macrophage Activation in a Multisite Randomized Trial.Cryptococcal Meningitis: Diagnosis and Management Update.Prevalence and Hospital Management of Amphotericin B Deoxycholate-Related Toxicities during Treatment of HIV-Associated Cryptococcal Meningitis in South AfricaRisk Factors for Cryptococcal Meningitis: A Single United States Center Experience.Clinical Presentation, Aetiology, and Outcomes of Meningitis in a Setting of High HIV and TB PrevalenceMLST-Based Population Genetic Analysis in a Global Context Reveals Clonality amongst Cryptococcus neoformans var. grubii VNI Isolates from HIV Patients in Southeastern Brazil.Dectin-3 Is Not Required for Protection against Cryptococcus neoformans Infection.Toxicity of Amphotericin B Deoxycholate-Based Induction Therapy in Patients with HIV-Associated Cryptococcal MeningitisIncreased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda.Immune correlates of HIV-associated cryptococcal meningitisFactors associated with early mycological clearance in HIV-associated cryptococcal meningitisAltered mental status is an indicator of mortality and associated with both infectious and non-communicable disease in Lilongwe, Malawi.Comparative genomics of Cryptococcus neoformans var. grubii associated with meningitis in HIV infected and uninfected patients in Vietnam.Cerebrospinal Fluid Culture Positivity and Clinical Outcomes After Amphotericin-Based Induction Therapy for Cryptococcal Meningitis.Brief Report: Effects of Tenofovir and Amphotericin B Deoxycholate Coadministration on Kidney Function in Patients Treated for Cryptococcal MeningitisHuman Immune Response Varies by the Degree of Relative Cryptococcal Antigen Shedding.Post-infectious inflammatory response syndrome (PIIRS): Dissociation of T-cell-macrophage signaling in previously healthy individuals with cryptococcal fungal meningoencephalitis.
P2860
Q26783210-BA5C365E-3988-46F8-B89F-2575EF0C4E7EQ26852378-9602E39C-5696-4F35-A12C-E62CFA4D367AQ28077707-63F6CDDB-F47A-4B4D-A4F7-39FFFAD1FB2AQ28078958-F7ABEACD-2BAF-44B0-9279-1B9F98FA1934Q30379272-BF3779EF-C8D9-496D-A458-BE66AFB9826EQ33765829-6D72DD48-F460-449D-9B79-9E4BD23FE20AQ33803185-2696F70E-F1F5-4599-8A98-BF92E146C65DQ33953918-945E0008-A79F-4B0E-A525-32668EB09112Q34202331-C801E234-3D5D-4268-81C9-E80E92A636B3Q35036181-CCC075A1-304D-43D3-887D-CB3E10EE08D4Q35054798-E624BA4D-BE6D-43B1-A6BC-65345B3E4E6AQ35072106-82D12F32-5BF0-40DC-8458-DD09BCD29315Q35208706-D7F82D8D-3F01-4226-9413-D261E93EA848Q35324835-57DEC759-D778-4CFA-93D4-5717C3EDC2DFQ35395169-0FE1AB35-DDA3-4DAA-B63C-A12AC1092F07Q35549784-A4D8AE69-40F1-4EDA-B4CE-1EB3B1BF0473Q35635476-B85EB274-95A1-4845-8F78-914B13B1F5B8Q35645083-EDF77887-2579-4451-91A7-BBA68B82FE10Q35664186-780BF617-A363-4A28-827C-0B0BEDFB5816Q35674504-4AB23017-F412-4D13-827C-2B8B2F2D927BQ35744569-878C508A-8822-4772-AB57-E9EE3B98BC62Q35776693-A5B8555B-94F7-4407-82F6-27CDBCFC2AA4Q35880502-980DFB94-EC62-4073-982B-5DB09B76DA36Q35923885-13147019-981C-4E62-BB61-5F54684FCC26Q35951094-432057A2-6413-48BA-9022-567FEF6D9684Q36088679-7BA64A61-75D9-4AC5-BBC1-7FC6A79D0720Q36097979-D9FA424A-CC5A-49F8-89BA-D6E20751336DQ36160866-96DDD486-A2EF-44C4-8FA8-6C2A73D190F4Q36252529-7D81184A-7525-4029-B7E5-B34861D6E291Q36255360-A2B8E2DD-5F36-44CA-AEDB-0945F933CAEBQ36290487-1821F1F8-51C5-486A-8BC7-22D1FF7BFF12Q36290696-815BA066-9C2B-4CE6-99DC-AC0B78EF7BB8Q36320051-85035B70-19CC-4F1E-9B69-1101AD365D1FQ36326762-5698ED8E-B237-4672-A63C-796FD055A069Q36362294-E4765917-1D18-4BAC-A47C-4772FB105D44Q36405450-35AD841D-966D-4BC5-A49F-BDDFA66EE2F9Q36407524-40147E80-E16C-49D0-AB09-6B25F2B557A8Q36463811-2F307E3C-B435-466E-A27D-FA032FC95FDDQ36488971-244022CF-1EB9-485D-BA90-589AF057F10FQ36781260-6F0248C0-DA64-46CE-A076-59F315CEF381
P2860
Determinants of mortality in a combined cohort of 501 patients with HIV-associated Cryptococcal meningitis: implications for improving outcomes.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
Determinants of mortality in a ...... ations for improving outcomes.
@en
Determinants of mortality in a ...... ations for improving outcomes.
@nl
type
label
Determinants of mortality in a ...... ations for improving outcomes.
@en
Determinants of mortality in a ...... ations for improving outcomes.
@nl
prefLabel
Determinants of mortality in a ...... ations for improving outcomes.
@en
Determinants of mortality in a ...... ations for improving outcomes.
@nl
P2093
P2860
P50
P921
P356
P1476
Determinants of mortality in a ...... ations for improving outcomes.
@en
P2093
Angela Loyse
Annemarie E Brouwer
Arthur Jackson
Conrad Muzoora
Creto Kanyembe
Daniel Namarika
Douglas Wilson
Jacob Phulusa
Jesse C Nussbaum
Kabanda Taseera
P2860
P304
P356
10.1093/CID/CIT794
P407
P50
P577
2013-12-06T00:00:00Z